The aim of this study was to establish the time-course of molecular events in intrascapular brown adipose tissue (iBAT) during the development of diet-induced obesity using microarrays and molecular network analysis. DESIGN: C57BL/6J male inbred mice were fed a high-fat diet (HFD) or normal diet (ND) and killed at multiple time-points over 24 weeks. METHODS: Global transcriptional changes in iBAT were determined by time-course microarrays of pooled RNA (n ¼ 6, pools per time-point) at 2, 4, 8, 20 and 24 weeks using Illumina MouseWG-6 v2.0 Beadchips. Molecular networks were constructed using the Ingenuity knowledgebase based on differentially expressed genes at each time-point. RESULTS: Body weight and subcutaneous adipose were progressively increased over 24 weeks, whereas iBAT was significantly increased between 6 and 12 weeks in HFD-fed C57BL/6J mice compared with controls. Blood glucose and insulin levels were increased between 16 and 24 weeks. Time-course microarrays, revealed 155 differentially expressed genes at one or more timepoints over 24 weeks in the iBAT of HFD-fed mice compared with controls. Time-course network analysis revealed a network of skeletal muscle development genes that was activated between 2 and 4 weeks, subsequently a network of immune trafficking genes was activated at 8 weeks. After 20 and 24 weeks, multiple lipid metabolism and immune response networks were activated. Several target genes identified by time-course microarrays were independently validated using RT-qPCR. Tnnc1 was upregulated early between 2 and 4 weeks, later Cd68 and Col1a1 were upregulated between 20 and 24 weeks, whereas 11b-hydroxysteroid dehydrogenase (Hsd11b1) was consistently downregulated during the development of diet-induced obesity. CONCLUSION: Molecular networks in iBAT are modulated in a time-dependent manner in response to a HFD. A broad range of gene targets exists to alter molecular changes within iBAT during the development of diet-induced obesity.
INTRODUCTION
Obesity represents a growing global health burden, with recent estimates reporting 1.46 billion adults are overweight, while 205 million men and 297 million women are obese. 1 Overweight and obesity are associated with significantly increased risk of multiple chronic diseases. 2 Obesity represents excess energy storage in adipose tissue depots. Two main types of fat exist, consisting of white adipose or brown adipose tissue. White adipose primarily stores energy, while brown adipose primarily uses energy for thermogenesis. 3 Brown adipose tissue is reported to have a role in diet-induced thermogenesis based on the observation that heat production after acute dietary intake exceeds basal metabolic rate. 3 In newborns, brown adipose tissue has an essential role in thermogenesis and generating heat. Many mammals retain brown fat into adulthood, but brown fat has long appeared to be lost in humans in early life during weaning. 4 Only recently has evidence emerged of functional brown adipose tissue in adult humans, 5 which has led to rapidly increased interest in whether changes in brown fat cause the development of obesity.
Several studies report that brown adipose tissue prevalence and activity is lower in obese humans. [5] [6] [7] Although, lower brown adipose tissue activity in obese humans may be due to the insulating effect of excess adipose tissue, hence reducing demands on thermogenesis. Nevertheless, intriguingly in morbidly obese individuals, a negative relationship exists between active brown adipose and body fat under conditions of maximal non-shivering. 8 White adipose tissue rapidly accumulates in high-fat diet (HFD) or western diet-fed animals. Brown adipose tissue accumulation is reported by some studies in response to a HFD 9 or cafeteria diet, 10 but some studies have been more equivocal. 3 Brown adipose tissue mass may be increased by adipocyte hypertrophy due to lipid droplet accumulation or by adipocyte hyperplasia due to proliferation and differentiation. However, the dynamics of brown adipose tissue accumulation in response to a HFD still need to be established.
Some studies indicate that brown adipose tissue may have a role in positive adaptation to a HFD. A recent global proteomic profiling study revealed increased protein levels of tricarboxylic acid cycle and oxidative phosphorylation enzymes in brown adipose tissue of C57BL/6J mice fed a HFD. 11 Another recent study indicated brown adipose tissue may be resistance to diet-induced inflammation. 12 Furthermore, genetic ablation of brown fat in mice using a toxigene results in increased fat accumulation in western diet-fed mice. 13 In addition, deletion of b-adrenergic receptors, required for brown adipose tissue activation, also results in increased HFD-induced obesity.
14 However, the actual timing of the molecular changes in brown adipose tissue during the natural development of diet-induced obesity remains to be established.
Time-course microarrays can provide a window into the molecular events underpinning changes in multiple tissues during diet-induced obesity. Dynamic changes in molecular networks can occur in different tissues and cells in response to extracellular stimuli. 15 Time-course microarray analysis of inflammation stimulated human leukocytes revealed activation of a dynamic molecular network in a time-dependent manner. 15 In addition, recently time-dependent changes in molecular networks were reported in liver in association with the development of nonalcoholic steatohepatitis triggered by a HFD. 16 Furthermore, molecular networks have been identified in adipose tissue of obese humans, 17 but our understanding of the timing and dynamics of network modulation especially in brown adipose tissue is limited.
Therefore, the aim of this study was first to establish the dynamics of intrascapular brown adipose tissue (iBAT) growth in response to a HFD. Second, to elucidate the time-course of molecular events in iBAT tissue in response to a prolonged HFD and finally to independently validate several target genes involved in the molecular changes in iBAT during the development of dietinduced obesity.
MATERIALS AND METHODS Animals
C57BL/6J male inbred mice (n ¼ 306) at age 4 weeks, were obtained from the Jackson Laboratory (Bar Harbor, ME, USA). All the mice were individually housed under a constant temperature (24 1C) and 12-h light/ dark cycle. An established diet-induced obesity model was used as reported previously. 18 Mice were fed the AIN-76 semi-purified diet for 1 week acclimation period. After the acclimation period, healthy mice were randomly divided into two groups: normal diet (ND) and a HFD 2, 4, 6, 8, 12, 16, 20 and 24 weeks. After the acclimation period, the HFD group was fed an AIN-76 semi-purified diet (American Institute of Nutrition, 1977) consisting of 20% w/w fat (B35% kcal) and 1% w/w cholesterol (Table 1) . Every 2-4 weeks, after a 12-h fast, blood samples were drawn from the inferior vena cava. Blood was collected in heparin-coated tubes, centrifuged at 1000 Â g for 15 min at 4 1C and then stored at À 70 1C. Mice were anaesthetized and killed at 0, 2, 4, 6, 8, 12, 16, 20 and 24 weeks. iBAT was dissected, rinsed, weighed immediately frozen in liquid nitrogen and stored at À 70 1C. Subcutaneous adipose tissue was dissected from the anterior and posterior depots, rinsed, weighed and discarded. The current study protocol was approved by the Ethics Committee for animal studies at Kyungpook National University, Republic of Korea.
RNA preparation and quality control Total RNA was extracted from iBAT using TRIZOL reagent (Invitrogen Life Technologies, Grand Island, NY, USA). DNase digestion was used to prevent any DNA contamination and RNA was reprecipitated in ethanol to prevent phenol contamination. RNA integrity was assessed using the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA). For five time-points (2, 4, 8, 20 and 24 weeks) , six pooled RNA sample sets were constructed to represent the ND and HFD group at each time-point as described previously. 19 RNA was stored at À 70 1C before further analysis by microarray and real-time quantitative-PCR (RT-qPCR).
Time-course microarray analysis
Time-course microarrays (n ¼ 30, arrays) were performed in iBAT from HFDor ND-fed mice covering five time-points (2, 4, 8, 20 and 24 weeks). Total RNA was converted into biotinylated cRNA using the Ambion Illumina RNA amplification kit (Ambion, Austin, TX, USA) and quantified using the ND-1000 Spectrophotometer (NanoDrop, Wilmington, DE, USA). Biotinylated cRNA (750 ng) was hybridized to Illumina MouseWG-6 v2 Expression BeadChips at 58 1C for 16-18 h, according to the manufacturer's instructions (Illumina Inc., San Diego, CA, USA). Detection of the array signal was carried out using Amersham fluorolink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK). Beadchips were scanned using the Illumina BeadArray Reader and raw data generated through the Illumina BeadStudio software (Illumina Inc.). Probe signal intensities were quantile normalized and log transformed. Significantly, differentially expressed genes at each time-point were determined by LIMMA using R/Bioconductor based on FDR o5%, Benjamin and Hochberg adjusted P-value o0.05 and log fold change 41 as previously reported. 18 Microarray data was deposited in the NCBI's Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/gds).
Molecular network analysis
Network analysis was conducted using the Ingenuity Knowledge base, which is a large repository of biological interactions between proteins, RNAs, genes, isoforms, metabolites, complexes, cells, tissues, drugs and diseases, manually curated by experts based on over 3.58 million published studies. 20 The Ingenuity Knowledge base, includes biological interaction data on 19 600 human and 14 700 mouse genes. For each time-point, molecular networks were constructed of direct physical, transcriptional and enzymatic interactions. Genes identified as differentially expressed were overlaid onto the interactome. Focus genes, which had direct interactions with other genes in Ingenuity Knowledge base were identified. For each focus gene, the specificity of connections was calculated by the percentage of its connections to other significant genes. Each network was constrained to a maximum of 35 genes. Network scores were calculated based on statistical likelihood. 15 The score indicates the likelihood that the assembly of a set of focus genes in a network could be explained by random chance alone. For each time-point, networks with a statistical likelihood score above 8 are presented. ); thiamin HCL 0.6, riboflavin 0.6, pyridoxine HCL 0.7, niacin 3, calcium pantothenate 1.6, folic acid 0.2, biotin 0.02, vitamin B 12 , vitamin A (500 000 U g 
RT-qPCR validation of microarrays
To validate microarray data, several differentially expressed genes of biological interest (11b-hydroxysteroid dehydrogenase type 1, Hsd11b1; cluster of differentiation 68, Cd68; troponin C type 1, Tnnc1; and collagen type 1 alpha 1, Col1a1) were measured independently by RT-qPCR using the same pooled RNA samples, which were hybridized to BeadChips. Total RNA (1 mg) was reverse-transcribed into complementary DNA using the QuantiTect reverse transcription kit (Qiagen, Hilden, Germany). Complementary DNA was then amplified using the SYBR green PCR kit (Qiagen) and gene specific primers to detect Hsd11b1:
0 on the CFX96TM real-time system (Bio-rad Ltd, Seoul, Korea). 21 C t data were normalized using glyceraldehyde-3-phosphate dehydrogenase, which was stably expressed in both HFD-and ND-fed mice. Relative gene expression was calculated with the 2 À DD C t method. 22 
Statistical analysis
All values are presented as mean±s.e.m. Significant differences between groups were determined by one-way analysis of variance (ANOVA) using the SPSS program (SPSS Inc., Chicago, IL, USA). The differences between the means were assessed using Duncan's multiple-range test. The results were considered statistically significant at Po0.05.
RESULTS
Time-course of changes in iBAT accumulation, blood glucose and insulin levels during the development of diet-induced obesity Body weight gain was significantly increased in a time-dependent manner in the HFD-fed mice ( Figure 1a ). Food efficiency ratio was significantly increased in the HFD-fed mice ( Figure 1b) . iBAT weight was significantly increased in the HFD-fed mice at 6, 8 and 12 weeks compared with the ND-fed mice, but plateaued thereafter ( Figure 1c ). Subcutaneous fat was significantly increased consistently in a time-dependent manner in the HFDfed mice over 24 weeks (Figure 1d ). Fasting blood glucose and insulin levels were significantly increased in the HFD-fed mice between 16 and 24 weeks (Figures 1e and f) . Blood lipid profiles were significantly altered during the development of diet-induced obesity. Plasma cholesterol and low-density lipoprotein-cholesterol were progressively increased early in the HFD-fed mice between 6 and 24 weeks, while high-density lipoproteincholesterol was significantly increased after 12 weeks and after 24 weeks compared with the ND-fed mice (Table 2) .
Time-course of changes in molecular networks in iBAT during the development of diet-induced obesity To identify molecular networks underlying changes in iBAT during diet-induced obesity, we first identified differentially expressed genes at five time-points over 24 weeks in HFD-fed mice. Overall, 155 genes were differentially expressed at one or more timepoints in iBAT (Supplementary File 1) , the top 10 differentially expressed genes at each time-point are shown in Table 3 . Ingenuity analysis of time-course microarrays revealed distinct and overlapping molecular networks in iBAT were modulated during the development of diet-induced obesity (Supplementary File 2). After 2 weeks, a network of developmental genes was predominantly upregulated in iBAT. Functional ontologies associated with this early-activated network were skeletal and muscular system development, tissue morphology, tissue development and embryonic development (Table 4 , Supplementary File 2). The main developmental-associated genes were (myosin light polypeptide 2, Myl2; troponin C type 1, Tnnc1; and troponin C type 2, Tnnc2). The focus genes in this developmental-associated network appeared to be progressively switched off and were no longer differentially expressed after 8 weeks. Network analysis of genes differentially expressed in iBAT after 4 weeks, revealed a closely overlapping network of upregulated developmental genes, expanded to include complement component 4B (C4b), lipid hydrolysis-related paraoxonase 1 (Pon1), as well as rupture of lens cataract (Rlc) and myosin light chain 3 (Myl3; Table 4 , Supplementary File 2). Genes present in these early networks were predominantly switched off after 4 weeks, with the exception of Pon1, which was consistently upregulated after 20 and 24 weeks. Network analysis of genes differentially expressed in iBAT after 8 weeks revealed a network associated with the immune response centered around immunity-related GTPase family M member 2 (Irgm2), guanylate binding protein 4 (Gbp4) and interferon gamma induced GTPase (Igtp), which are all induced by IFNg and were consistently upregulated in iBAT at 2, 4 and 8 weeks (Table 4 , Supplementary File 2). Functional ontologies associated with this network were immune cell trafficking, including leukocyte activation (P ¼ 1.32E À 12) and lymphocyte activation (P ¼ 2.59E À 13). Network analysis of genes differentially expressed after 20 weeks revealed a dense lipid metabolism network centered around leptin (Lep), which was upregulated, many genes were also connected to extracellular cholesterol (Table 4 , Supplementary File 2). Functional ontologies associated with this lipid metabolism network were efflux of cholesterol (P ¼ 9.79E À 09), uptake of lipid (P ¼ 7.59E À 08) and secretion of lipid (P ¼ 1.24E À 06). Genes in this lipid metabolism network were Table 4 ). Genes in these networks were predominantly modulated only later during the development of diet-induced obesity. The immune response networks and cell proliferation network were predominantly upregulated in iBAT after 24 weeks. The lipid metabolism networks revealed both up and downregulated genes ( Figure 2 ).
RT-qPCR validation of time-course microarrays in iBAT during the development of diet-induced obesity Several genes identified as differentially expressed at one or more time-points over 24 weeks based on microarray analysis and which were also part of the molecular networks identified in iBAT were independently validated by RT-qPCR. Hsd11b1 was consistently suppressed by high-fat intake with comparable changes indicated by microarray and RT-qPCR (Figure 3a ). CD68 antigen (Cd68), a marker of immune cell infiltration, was markedly increased between 20 and 24 weeks in HFD mice (Figure 3b ).
Tnnc1 a skeletal muscle protein, was markedly upregulated between 2 and 4 weeks based on microarray, but changes were less prominent based on RT-qPCR. Nevertheless, RT-qPCR revealed Tnnc1 was progressively downregulated during the later stages of diet-induced obesity (Figure 3c ). Col1a1 a procollagen protein, was increased between 20 and 24 weeks indicated by both microarray and RT-qPCR (Figure 3d ).
DISCUSSION
Brown adipose tissue is an attractive therapeutic target to reverse obesity based on its thermogenic capacity, however, we have little understanding of the time-course of molecular events, which occur in iBAT during the development of obesity. Molecular networks associated with skeletal muscle development were active in iBAT early during the development of diet-induced obesity, followed by modulation of immune cell trafficking, lipid uptake and lipid secretion networks. Later during the development of diet-induced obesity, molecular networks associated with the immune system, lipid metabolism and connective tissue development were modulated in iBAT. In mice, iBAT has been reported to increase, decrease or remain unchanged in mice fed a HFD for varying durations. 3 Here we show iBAT accumulation, assessed at eight time-points over 24 weeks, significantly increased after 6 weeks and plateaued after 12 weeks. In contrast, subcutaneous adipose tissue progressively expanded over 24 weeks in response to a HFD. Several factors may contribute to iBAT accumulation in response to high-fat intake. For example, an increase in lipid droplet storage can cause brown adipocyte hypertrophy, an increase in brown adipogenesis can cause brown adipocyte hyperplasia or the development of inflammation can lead to fibrosis. The plateau in iBAT growth after 12 weeks despite continued high-fat intake was unexpected, but it suggests there is a limited lipid storage capacity in iBAT. Even after iBAT growth plateaued, changes in molecular networks were evident, which indicates molecular changes occurring inside iBAT despite no additional expansion. There have been few other studies, which have examined the dynamics of adipose tissue depot expansion in response to a HFD and controlled for agerelated growth. Recently, we reported that in HFD-fed mice growth of the retroperitoneum adipose depot starts to plateau after 12 weeks. 23 Growth of the epididydmal adipose depot starts to plateau after 16 weeks, whereas the perirenal depot continues to expand after 20 weeks. 23 Time-course network analysis of gene expression data provides a unique window into the changes occurring at the molecular level within a tissue, which may have been due to functional adaptation to protect against obesity, or due to the pathophysiological consequences of high-fat intake. Important cellular markers of brown fat activation are UCP1 and mitochondrial enzyme activity. UCP1 is an uncoupling protein responsible for mitochondrial proton leakage, which generates heat during brown fat thermogenesis. Despite many studies reporting UCP1 mRNA and protein levels in diet-induced obese animals, 24 there is no clear consensus on whether UCP1 in iBAT is regulated in response to a HFD. In the present study, time-course microarray analysis revealed no significant regulation of UCP family members over 24 weeks in HFD-fed mice. The wide variation in brown fat UCP1 levels reported previously in dietinduced obese mice, may be partly due to varying basal UCP1 activation. 24 Nevertheless, transgenic expression of UCP1 is reported to protect against obesity. Conversely, mice with UCP1 deletion are susceptible to diet-induced obesity when housed under thermoneutral conditions. 25 Therefore, while UCP1 appears not to be changed during the natural progression of diet-induced obesity, past studies indicate UCP1 is a bona fide target to activate brown adipose tissue thermogenesis and counter-act obesity.
Brown adipocytes belong to the myogenic lineage, and share common precursor cells with skeletal muscle myocytes. 26 Myogenic and skeletal muscle developmental genes are reported to be downregulated during brown adipocyte differentiation. 27 In the present study, we observed skeletal muscle developmental genes were activated early between 2 and 4 weeks, which suggests that remodeling may occur in iBAT in response to high-fat intake. Cytochrome c oxidase subunit VI a polypeptide 2 (Cox6a2) a mitochondrial gene was also concomitantly upregulated, although we observed no coordinated upregulation of mitochondrial gene expression. Time-course microarrays revealed no detectable modulation of Prdm16, a regulator of brown adipogenesis at any time-point during the developing of diet-induced obesity. 28 Brown adipogenesis is known to be accompanied by a concerted upregulation of extracellular matrix genes and downregulation of cell cycle regulators, 27 which were not observed in the present study during the early stages of diet-induced obesity. The skeletal Time-course microarray in BAT RA McGregor et al muscle developmental genes were progressively switched off after 8 weeks and were not modulated during the later stages of diet-induced obesity. Brown adipose tissue is specialized in lipid catabolism, in contrast to white adipose tissue, which primarily stores lipids. Nevertheless, the early expansion of iBAT between 6 and 12 weeks in response to high-fat intake may predominantly be due to lipid storage. Previous studies indicate HFD causes increased lipid droplet accumulation in iBAT. 12, 29 Lipid uptake and secretion genes were differentially expressed after 20 weeks of HFD, following a rapid increase in relative iBAT. Our findings indicate late changes in lipid metabolism gene expression may be part of a positive adaptation to slow down lipid accumulation in iBAT.
Pon1 a high-density lipoprotein-associated antioxidant enzyme, was also upregulated later in diet-induced obesity. Pon1 prevents oxidation of low-density lipoprotein therefore may protect against atherosclerosis, also Pon1 is reported to inhibit diacylglycerol acyltransferase 1 activity and therefore can suppress triglyceride accumulation. 30 Conversely, acetyl-coA synthetase family members (Acsl5 and Accss2) and a long chain fatty acid elongase, Elovl6 were downregulated between 20 and 24 weeks, indicating fatty acid synthesis in iBAT was suppressed. Sterol synthesis was also suppressed at 24 weeks, indicated by downregulation of phosphomevalonate kinase (Pmvk) and NAD(P) dependent steroid dehydrogenase-like (Nsdhl), which catalyzes steps in the sterol biosynthesis pathway. Acyl-coA thioesterase 1 (Acot1), a thioesterase family member, which has a role in long-chain fatty acid metabolism was upregulated at 24 weeks. Thioesterase superfamily member genes are highly expressed in brown adipose tissue and gene knockdown protects mice against diet-induced obesity and related metabolic abnormalities. 31 Lep was also found to be upregulated, although a immunohistochemical localization study reported Lep is not present in UCP positive brown adipocytes, but is present at the periphery of iBAT in unilocular UCP-negative adipocytes. 32 Taken together, the present findings indicate an adaptive response may occur to suppress fatty acid synthesis and sterol biosynthesis in iBAT during the later stages of diet-induced obesity.
Diet-induced obesity is closely associated with inflammation. 33, 34 In white adipose tissue, immune cell infiltration is evident in obese animals and humans. 35 However, whether inflammation occurs in iBAT due to diet-induced obesity is less well established. We found evidence of a robust upregulation of immune response gene networks at 24 weeks. Immune response related gene changes indicated a broad infiltration of leukocytes, monocytes and macrophages (CD44 antigen, Cd44; CD52 antigen, Cd52; CD68 antigen, Cd68; CD84 antigen, Cd84) into iBAT, as well as complement pathway activation in the later stages of dietinduced obesity. However, a recent study suggested brown adipose tissue of C57BL/6J mice is resistant to inflammation induced by a high-fat (45% kcal) diet. 12 In this previous study, global gene expression profiling found no evidence of genes associated with the immune response at 13 weeks, and immunostaining revealed absence of macrophage markers in BAT after 13 or 20 weeks. 12 Although, another recent study reported evidence of inflammation in BAT after 15 weeks in cafeteria dietfed animals. 29 Furthermore, blocking inflammation protects brown adipose tissue, based on evidence that TNFa deletion in mice decreases apoptosis and lipid droplet stores in brown adipose tissue. 36 The present findings indicate iBAT is not immune to dietinduced inflammation, but compared with other adipose tissue depots inflammation may be delayed, therefore inflammatory gene expression signatures may only be detectable in long-term diet-induced obesity models.
The activation of immune gene networks coincided with the activation of a connective tissue development gene network after 24 weeks of high-fat intake. In liver and white adipose tissue fibrosis is often evident in diet-induced obese mice, 37, 38 however, whether fibrosis occurs in brown fat remains to be established. The connective tissue development network included procollagen genes (Col1a1; collagen type V alpha 1, Col5a1) and procollagen C-endopeptidase enhancer (Pcolce) involved in procollagen cleavage, as well as actin remodeling genes. Absence of procollagen expression in white adipose tissue allows for uninhibited expansion of adipocytes, improves energy homeostasis and reduces inflammatory biomarkers in dietinduced mice, 39 whether similar consequences occur in brown adipose tissue is not known. Extracellular remodeling and cell motility (actin b, Actb; coactosin-like 1, Cotl1; coronin actin binding protein 1A, Coro1a; NCK-associated protein 1, Nckap1; lipoma HMGIC fusion partner-like 3, Lhfpl3; mannose receptor C type 1, Mrc1) associated genes were modulated in brown adipose tissue during the later stages of diet-induced obesity. Although the upregulation of actin remodeling and cell motility-associated genes maybe indicative of brown fat adipogenesis, a more plausible explanation is actin remodeling that occurs to accommodate the expansion of brown adipose tissue to cope with the excess free-fatty acid supply from the diet, as well as the infiltration of immune cells. Apoptosis-associated genes were also upregulated including paternally expressed 3 (Peg3), which has a role in TNFa signaling transduction 40 and cathepsin H (Ctsh), which is involved in the degradation of protein in lysozomes. 41 Taken together, the present findings suggest inflammation and associated changes including fibrosis occur in iBAT much later during the development of diet-induced obesity, therefore may not be observed in short-term diet-induced obesity studies. Furthermore, modulation of actin cytoskeleton-associated genes appears to underlie the expansion of iBAT during the early stages of diet-induced obesity, alongside concomitant activation of apoptosis-associated genes.
Despite the pathological changes such as immune cell infiltration and fibrosis occurring in iBAT, transcriptional inhibition of 11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1) appears to be a surprising positive adaptation in brown adipose tissue. 11b-HSD1 encodes an enzyme that triggers conversion of cortisone to cortisol in a tissue specific manner. Others have reported Hsd11b1 appears to be inhibited in different adipose tissue depots by long-term diet-induced obesity in C57BL/6J and A/J mice. 42 Elevated glucocorticoid levels are associated with obesity and metabolic syndrome. Hsd11b1 expression is increased in visceral and subcutaneous white adipose tissue of obese humans. 43 Transgenic expression of 11b-HSD1 from the aP2 promoter increases adipose tissue glucocorticoid reactivation resulting in metabolic syndrome. 44 Conversely, deficiency of 11b-HSD1 prevents metabolic abnormalities associated with diet-induced obesity. 45 Pharmacological 11b-HSD1 inhibitors may also be effective at reducing metabolic syndrome risk factors. 46 Furthermore, several reports indicate 11b-HSD1 can be nutritionally modulated for example with flavone, quercetin or coffee extract. 44 However, the full repertoire of 11b-HSD1 regulators in iBAT remains to be elucidated. We acknowledge that gene expression can be post-transcriptionally regulated, 47 nevertheless time-course microarrays provide a unique window into the dynamics of molecular events underlying physiological responses to dietary interventions. In future studies, time-course microarrays can be used to understand molecular changes in response to nutritional interventions to prevent obesity and related comorbidities such as type 2 diabetes.
In conclusion, a long-term (B35% kcal) HFD in C57BL/6J mice resulted in iBAT expansion between 6 and 12 weeks, before reaching a plateau. Molecular networks associated with skeletal muscle development are active in iBAT during the early stages of diet-induced obesity. But during the later stages of diet-induced obesity, molecular networks associated with immune cell trafficking, lipid metabolism and connective tissue development networks are modulated. Tnnc1, Cd68, Col1a1 and Hsd11b1 were identified as potential gene targets involved in molecular networks, which are altered during the development of dietinduced obesity in iBAT.
